MENU
+Compare
AKYA
Stock ticker: NASDAQ
AS OF
May 30 closing price
Price
$1.25
Change
+$0.01 (+0.81%)
Capitalization
230.47M

AKYA Akoya BioSciences Forecast, Technical & Fundamental Analysis

Akoya Biosciences Inc is a life sciences technology company... Show more

AKYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AKYA with price predictions
May 30, 2025

AKYA in upward trend: price may jump up because it broke its lower Bollinger Band on May 13, 2025

AKYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where AKYA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AKYA's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on May 21, 2025. You may want to consider a long position or call options on AKYA as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AKYA just turned positive on May 20, 2025. Looking at past instances where AKYA's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

AKYA moved above its 50-day moving average on May 30, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKYA advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 44 cases where AKYA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.167) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.097) is also within normal values, averaging (42.393).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AKYA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
AKYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AKYA is expected to report earnings to fall 41.41% to -18 cents per share on August 11

Akoya BioSciences AKYA Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
Q2'24
Est.
$-0.27
The last earnings report on May 13 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 105.61K shares outstanding, the current market capitalization sits at 230.47M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 855 896-8401
Employees
330
Web
https://www.akoyabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVRTX28.130.01
+0.04%
VY® CBRE Real Estate S2
FEVAX21.77-0.02
-0.09%
First Eagle US A
REIGX16.15-0.05
-0.31%
Federated Hermes International Growth R6
FSZZX9.56-0.11
-1.14%
Fidelity Advisor Sustainable EM Eq Z
SEMNX17.88-0.23
-1.27%
Hartford Schroders Emerging Mkts Eq I

AKYA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AKYA has been loosely correlated with BLFS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AKYA jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKYA
1D Price
Change %
AKYA100%
+0.81%
BLFS - AKYA
42%
Loosely correlated
-1.97%
MXCT - AKYA
41%
Loosely correlated
+3.03%
RGEN - AKYA
38%
Loosely correlated
-3.47%
BRKR - AKYA
38%
Loosely correlated
-1.50%
VCYT - AKYA
38%
Loosely correlated
-1.30%
More